ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

4.6%

10.0%

15.8%

31.8%

16.4%

71.4%

28.4%

10y

24.8%

all

16.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 8,872 4.6%

6,502

9,050

Company Overview

Sales

1,619 Cr

Growth: 26.3%

Profit after Tax

97 Cr

Growth: 18.4%

Mid Cap

22,179 Cr

P/E: 228.8x

Industry P/E: 29.6x

Fundamentals

Sales (Cr)	₹ 1,619
Growth	26.3%
EBITDA	13.4%
P/S	13.7x
Dividend	0.3%
P/E	228.8x
Book Value	₹ 308
PEG Ratio	8.7x
ROE	13.3%
P/B	28.8x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory.Core Therapy AreasCardiovascularOncologyRespiratoryMilestones and achievements1979: Astra IDL formation.1982: Astra factory foundation.1992: Launch of Cerviprime, Plendil, Ramace, Rhinocort and Imdur.

Belongs to (22 Indices) view more

Investors (43)

astra.ph...

all.body...

mansfiel...

Followers (3)

nitin2

keerthi

deepak